Literature DB >> 18460289

Atrial fibrillation and congestive heart failure.

Noel G Boyle1, Kalyanam Shivkumar.   

Abstract

Atrial fibrillation (AF) and congestive heart failure (CHF) are common cardiac conditions that frequently coexist. There is a complex interplay between the two conditions, with each increasing the morbidity and mortality associated with the other. The management of AF in patients with CHF requires special care because of the increased risk of antiarrhythmic drug therapy in the group. This report reviews current treatment options and assesses the role of the newer therapies of biventricular pacing for CHF and radiofrequency ablation for AF. It also discusses results of the AF-CHF study, which were reported in November 2007.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18460289     DOI： 10.1007/s11897-008-0003-3

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN： 1546-9530


  35 in total

1.  Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation.

Authors:  C Leclercq; S Walker; C Linde; J Clementy; A J Marshall; P Ritter; P Djiane; P Mabo; T Levy; F Gadler; C Bailleul; J-C Daubert
Journal:  Eur Heart J       Date:  2002-11       Impact factor: 29.983

2.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

Review 3.  The novel antiarrhythmic drug dronedarone: comparison with amiodarone.

Authors:  Sven Kathofer; Dierk Thomas; Christoph A Karle
Journal:  Cardiovasc Drug Rev       Date:  2005

Review 4.  Systematic review of the management of atrial fibrillation in patients with heart failure.

Authors:  A U Khand; A C Rankin; G C Kaye; J G Cleland
Journal:  Eur Heart J       Date:  2000-04       Impact factor: 29.983

Review 5.  Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets.

Authors:  Joachim R Ehrlich; Stanley Nattel; Stefan H Hohnloser
Journal:  J Cardiovasc Electrophysiol       Date:  2002-04

6.  Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction.

Authors:  O D Pedersen; H Bagger; L Kober; C Torp-Pedersen
Journal:  Circulation       Date:  1999-07-27       Impact factor: 29.690

Review 7.  Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Daniel E Singer; Gregory W Albers; James E Dalen; Alan S Go; Jonathan L Halperin; Warren J Manning
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

8.  Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure.

Authors:  Demetris Yannopoulos; Keith G Lurie; Scott Sakaguchi; Simon Milstein; Cengiz Ermis; Laura VanHeel; David G Benditt
Journal:  J Am Coll Cardiol       Date:  2007-09-10       Impact factor: 24.094

9.  Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation.

Authors:  Nicolas Lellouche; Carlos De Diego; Marmar Vaseghi; Eric Buch; David A Cesario; Aman Mahajan; Isaac Wiener; Gregg C Fonarow; Noel G Boyle; Kalyanam Shivkumar
Journal:  Pacing Clin Electrophysiol       Date:  2007-11       Impact factor: 1.976

10.  Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

Authors:  H C Doval; D R Nul; H O Grancelli; S V Perrone; G R Bortman; R Curiel
Journal:  Lancet       Date:  1994-08-20       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.